P
PRPO
Precipio Inc
27.25
-0.57-2.05%After Hours: 28.10 +0.85 +3.12%17:39 04/10 EDT
OPEN/PREV CLOSE27.82/27.82
TODAY RANGE26.06-28.16
VOL52.38K
MARKET CAP48.61M
52 WEEK RANGE3.900-29.53
AVG VOL (3M)21.54K
% TURNOVER2.94%
TURNOVER--
P/E (TTM)-120.4686
% RANGE6.99%
EPS(TTM)-0.2262
P/E(FORWARD)1.662
P/B3.333
BVPS8.18
DIVIDEND--
P/S2.018
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP42.83M
SHARES OUTSTANDING1.78M
NEXT EARNINGS05/12-05/18
FREE FLOAT1.57M
LOT SIZE1
EX-DATE09/22/2023
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
Precipio Earnings Call Signals Profitable Growth Pivot
Seeking Alpha·5d ago
Precipio GAAP EPS of -$0.23, revenue of $24.05M
Seeking Alpha·04/02 14:00
Here are the major earnings after the close Thursday
Benzinga·04/02 11:11
Earnings Scheduled For April 2, 2026
Reuters·03/30 21:41
Precipio FY25 net sales climb 30% to $24M; operating loss narrows to $1.2M
Seeking Alpha·03/29 12:07
Earnings week ahead: NKE, TLRY, SPCE, BYND, NNDM, CAG, and more
Reuters·03/12 21:00
Precipio Inc. to Host Q4 and Year-End 2025 Shareholder Update Call
TipRanks·03/10 13:05
Precipio announces publication in Journal of Clinical Pathology
Reuters·02/25 14:44
Blood cancer diagnostics firm Precipio's prelim Q4 revenue rises 23%
Dow Jones·02/25 14:38
*Precipio 4Q Rev $6.7M >PRPO
Dow Jones·02/25 14:38
*Precipio 4Q Net $500,000 >PRPO
TipRanks·02/25 14:36
Precipio reports FY25 revenue $24M vs. $18.5M last year
Benzinga·02/25 14:33
Precipio Q4 2025 Preliminary Revenue $6.7M, An Increase Of 23% From $5.4M YoY